Details for New Drug Application (NDA): 021160
✉ Email this page to a colleague
The generic ingredient in PHOSLO GELCAPS is calcium acetate. There are two hundred and eighty-two drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the calcium acetate profile page.
Summary for 021160
Tradename: | PHOSLO GELCAPS |
Applicant: | Fresenius Medcl |
Ingredient: | calcium acetate |
Patents: | 0 |
Suppliers and Packaging for NDA: 021160
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PHOSLO | calcium acetate | CAPSULE;ORAL | 021160 | NDA AUTHORIZED GENERIC | Sandoz Inc | 0781-2081 | 0781-2081-02 | 200 CAPSULE in 1 BOTTLE (0781-2081-02) |
PHOSLO | calcium acetate | CAPSULE;ORAL | 021160 | NDA AUTHORIZED GENERIC | Sandoz Inc | 0781-2672 | 0781-2672-02 | 200 CAPSULE in 1 BOTTLE (0781-2672-02) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 333.5MG | ||||
Approval Date: | Apr 2, 2001 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 667MG | ||||
Approval Date: | Apr 2, 2001 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 667MG | ||||
Approval Date: | Apr 2, 2001 | TE: | RLD: | Yes |
Expired US Patents for NDA 021160
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Fresenius Medcl | PHOSLO | calcium acetate | CAPSULE;ORAL | 021160-001 | Apr 2, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Fresenius Medcl | PHOSLO GELCAPS | calcium acetate | CAPSULE;ORAL | 021160-003 | Apr 2, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Fresenius Medcl | PHOSLO GELCAPS | calcium acetate | CAPSULE;ORAL | 021160-003 | Apr 2, 2001 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription